DTPa-HBV-IPV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DTPa-HBV-IPV, covering 2017-06-16 to 2017-06-16. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately [Phase 3]